✦ LIBER ✦

Changes in serum interleukin-6 and high-sensitivity C-reactive protein levels in patients with acute coronary syndrome and their responses to simvastatin

✍ Scribed by Yumei Luo; Deqian Jiang; Dan Wen; Jianxin Yang; Liying Li

Publisher: Springer
Year: 2004
Tongue: English
Weight: 231 KB
Volume: 19
Category: Article
ISSN: 0910-8327
DOI: 10.1007/s00380-004-0776-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Response of high-sensitivity C-reactive

Response of high-sensitivity C-reactive protein to percutaneous coronary intervention in patients with acute coronary syndrome

✍ Kyeong Ho Yun; Myung Ho Jeong; Seok Kyu Oh; Sang Jae Rhee; Eun Mi Park; Eun Mi L 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 239 KB

Association between percutaneous coronar

Association between percutaneous coronary intervention and long-term C-reactive protein levels in patients with acute coronary syndromes

✍ Kausik K. Ray; Babak Nazer; Richard Cairns; C. Michael Gibson; Christopher P. Ca 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 168 KB

Serum levels of cytokines and C-reactive

Serum levels of cytokines and C-reactive protein in acute ischemic stroke patients, and their relationship to stroke lateralization, type, and infarct volume

✍ Heidi Ormstad; Hans Christian Dalsbotten Aass; Niels Lund-Sørensen; Karl-Friedri 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 200 KB

Erratum to: Serum levels of cytokines an

Erratum to: Serum levels of cytokines and C-reactive protein in acute ischemic stroke patients, and their relationship to stroke lateralization, type, and infarct volume

✍ Heidi Ormstad; Hans Christian Dalsbotten Aass; Niels Lund-Sørensen; Karl-Friedri 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 89 KB

High sensitive serum C-reactive protein

High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome

✍ Fatma Ferda Verit 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 184 KB

Thalidomide reduces serum C-reactive pro

Thalidomide reduces serum C-reactive protein and interleukin-6 and induces response to IL-2 in a fraction of metastatic renal cell cancer patients who failed IL-2-based therapy

✍ Igal Kedar; Wilmosh Mermershtain; Hefziba Ivgi 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 341 KB

## Abstract Interleukin‐2 (IL‐2) has some antitumor activity in patients with renal cell carcinoma. It has been noted that response to IL‐2 and prognosis may be adversely affected by elevated serum levels of C‐reactive protein (CRP) or interleukin‐6 (IL‐6). We used thalidomide to treat patients wit